The Effects of Human Immunodeficiency Virus in the Central Nervous System

Advances in Virus Research

Volumn 50, Issue C, 1998, Pages 1-47

  Kolson, Dennis L ^a   Lavi, Ehud ^a   González Scarano, Francisco ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; REVIEW; VIROLOGY;

AIDS DEMENTIA COMPLEX; HIV-1; HUMANS;

EID: 0031601670     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/S0065-3527(08)60804-0     Document Type: Article

References (250)

1. Achim, C.L., Heyes, M.P., Wiley, C.A., Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J. Clin. Invest. 91 (1993), 2769–2775.
2. Adamson, D.C., Wildemann, B., Sasaki, M., Glass, J.D., McArthur, J.C., Christov, V.I., Dawson, T.M., Dawson, V.L., Immunologic NO synthase: Elevation in severe AIDS dementia and induction by gp41. Science 274 (1996), 1917–1921.
3. Adle-Biassette, H., Levy, Y., Colombel, M., Poron, F., Natchev, S., Keohane, C., Gray, F., Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol. 21 (1995), 218–227.
4. Albright, A.V., Strizki, J., Harouse, J.M., Lavi, E., O'Connor, M., González-Scarano, F., HIV-1 infection of cultured human adult oligodendrocytes. Virology 217 (1996), 211–219.
5. Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E., Murphy, P.M., Berger, E.A., CC CKR5: A RANTES, MIP-1α, MIP-1/β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272 (1996), 1955–1958.
6. Apostolski, S., McAlarney, T., Quattrini, A., Levison, S.W., Rosoklija, G., Lugaressi, A., Corbo, M., Sadiq, S.A., Lederman, S., Hays, A.P., Latov, N., The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann. Neurol. 34 (1993), 855–863.
7. Arriza, J.L., Fairman, W.A., Wadiche, J.I., Murdoch, G.H., Kavanaugh, M.P., Amara, S.G., Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14 (1994), 5559–5569.
8. Atwood, W.J., Berger, J.R., Kaderman, R., Tornatore, C.S., Major, E.O., Human immunodeficiency virus type 1 infection of the brain. Clin. Microbiol. Rev. 6 (1993), 339–366.
9. Bagasra, O., Lavi, E., Bobroski, L., Khalili, K., Pestaner, J.P., Pomerantz, R.J., Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ PCR and immunohistochemistry. AIDS 10 (1996), 573–585.
10. Barillari, G., Gendelman, R., Gallo, R.C., Ensoli, B., The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 7941–7945.
11. Barks, J.D.E., Sun, R., Malinak, C., Silverstein, F.S., Gp120, an HIV-1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rats. Exp. Neurol. 132 (1995), 123–133.
12. Bell, J.E., Busuttil, A., Ironside, J.W., Human immunodeficiency virus and the brain: Investigation of virus load and neuropathologic changes in pre-AIDS subjects. J. Infect. Dis. 168 (1993), 818–824.
13. Bennett, B.A., Rusyniak, D.E., Hollingsworth, C.K., HIV-1 gp120–induced neurotoxicity to midbrain dopamine cultures. Brain Res. 705 (1995), 168–176.
14. Benos, D.J., Hahn, B.H., Bubien, J.K., Ghosh, S.K., Mashburn, N.A., Chaikin, M.A., Shaw, G.M., Benveniste, E.N., Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: Implications for AIDS dementia complex. Proc. Natl. Acad. Sci. U.S.A. 91 (1994), 494–498.
15. Benos, D.J., McPherson, S., Hahn, B.H., Chaikin, M.A., Benveniste, E.N., Cytokines and HIV envelope glycoprotein gp120 stimulate Na+/H+ exchange in astrocytes. J. Biol. Chem. 269 (1994), 13811–13816.
16. Benveniste, E.N., Cytokine circuits in brain. Implications for AIDS dementia complex. Price, R.W., Perry, S.W., (eds.) “HIV, AIDS, and the Brain”, 1994, Raven Press, New York, 71–88.
17. Bhat, S., Spitalnik, S.L., Gonzalez-Scarano, F., Silberberg, D.H., Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope gp120. Proc. Natl. Acad. Sci. U.S.A. 88 (1991), 7131–7134.
18. Bo, L., Dawson, T.M., Wesselingh, S., Mork, S., Choi, S., Kong, P.A., Hanley, D., Trapp, B.D., Induction of nitric oxide synthase in demylinating regions of multiple sclerosis brains. Ann. Neurol. 36 (1994), 778–786.
19. Brake, D.A., Debouck, C., Biesecker, G., Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein. Tat. J. Cell Biol. 111 (1990), 1275–1281.
20. Bredt, D.S., Glatt, C.E., Hwang, P.M., Fotuhi, M., Dawson, T.M., Snyder, S.H., Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 7 (1991), 615–624.
21. Brenneman, D.E., Westbrook, G.L., Fitzgerald, S.P., Ennist, D.L., Elkins, K.L., Ruff, M.R., Pert, C.B., Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (London) 335 (1988), 639–642.
22. Brew, B.J., Corbeil, J., Pemberton, L., Evans, L., Saito, K., Penny, R., Cooper, D.A., Heyes, M.P., Quinolinic acid production is related to macrophage tropic isolates of HIV-1. J. Neurovirol. 1 (1995), 369–374.
23. Brew, B.J., Rosenblum, M., Cronin, K., Price, R.W., AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations. Ann. Neurol. 38 (1995), 563–570.
24. Brosnan, C.F., Battistini, L., Raine, C.S., Dickson, D.W., Casadevall, A., Lee, S.C., Reactive nitrogen intermediates in human neuropathology: An overview. Dev. Neurosci. 16 (1994), 152–161.
25. Budka, H., Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1 (1991), 163–175.
26. Budka, H., Lassman, H., Human immunodeficiency virus in glial cells?. J. Infect. Dis., 157, 1988, 203.
27. Budka, H., Costanzi, G., Cristina, S., Lechi, A., Parravicini, C., Trabattoni, R., Vago, L., Brain pathology induced by infection with the HIV: A histological, immunocytochemical, and EM study of 100 autopsy cases. Acta Neuropathol. (Berlin) 75 (1987), 185–198.
28. Bukrinsky, M.I., Nottet, H.S., Schmidtmayerova, L.M.H., Dubrovsky, L., Flanagan, C.R., Mullins, M.E., Lipton, S.A., Gendelman, H.E., Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J. Exp. Med. 181 (1995), 735–745.
29. Buzy, J., Brenneman, D.E., Pert, C.B., Martin, A., Salazar, A., Ruff, M.R., Potent gp120–like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals in blocked by peptide T. Brain Res. 598 (1992), 10–18.
30. Ceroni, M., Minoli, L., Di Perri, G., Senaldi, G., Marone, P., Achilli, G., Mondelli, M., Camana, C., Detection of HTLV-III specific IgG bands in the CSF from a patient with AIDS and encephalitis. Neurology 38 (1988), 143–144.
31. Chao, C.C., Hu, S., Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16 (1994), 172–179.
32. Chaudhry, F.A., Lehre, K.P., van Lookeren Campagne, M., Ottersen, O.P., Danbolt, N.C., Storm-Mathisen, J., Glutamate transporters in glial plasma membranes: Highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15 (1995), 711–720.
33. Cheng-Mayer, C., Levy, J.A., Distinct biological and serological properties of human immunodeficiency virus from the brain. Ann. Neurol. 23 (1988), S58–S61 Suppl.
34. Chesebro, B., Wehrly, K., Nishio, J., Perryman, S., Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J. Virol. 66 (1992), 6547–6554.
35. Chiodi, F., Keys, B., Albert, J., Hagberg, L., Lundeberg, J., Uhlén, M., Fenyö, E.M., Norkrans, G., Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J. Clin. Microbiol. 30 (1992), 1768–1771.
36. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P.D., Wu, J., Mackay, C.R., LaRosa, G., Newman, W., Gerard, N., Gerard, C., Sodroski, J., The b-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85 (1996), 1135–1148.
37. Ciardo, A., Meldolesi, J., Effects of the HIV-1 envelope glycoprotein gp120 in cerebellar cultures. [Ca2+]i increases in a glial cell subpopulation. Eur. J. Neurosci. 5 (1993), 1711–1718.
38. Conant, K., Ma, M., Nath, A., Major, E.O., Extracellular human immunodeficiency virus type 1 tat protein is associated with an increase in both NF-B binding and protein kinase C activity in primary human astrocytes. J. Virol. 70 (1996), 1384–1389.
39. Corboy, J.R., Buzy, J.M., Zink, C., Clements, J.E., Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258 (1992), 1804–1808.
40. Cortey, A., Jarvik, J.G., Lenkinski, R.E., Grossman, R.I., Frank, I., Delivoria-Papadopoulos, M., Proton MR spectroscopy of brain abnormalities in neonates born to HIV-positive mothers. Am. J. Neuroradiol. 15 (1994), 1853–1859.
41. Cupp, C., Taylor, J.P., Khalili, K., Amini, S., Evidence for stimulation of the transforming growth factor β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8 (1993), 2231–2236.
42. David, L.E., Hjelle, B.L., Miller, V.E., Palmer, D.L., Llewellyn, A.L., Merlin, T.L., Young, S.A., Mills, R.G., Wachsman, W., Wiley, C.A., Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42 (1992), 1736–1739.
43. Dawson, T.M., Dawson, V.L., Snyder, S.S., A novel neuronal messenger molecule in brain: The free radical, nitric oxide. Ann. Neurol. 32 (1992), 297–311.
44. Dawson, V.L., Dawson, T., Uhl, G.R., Snyder, S.H., Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 3256–3259.
45. de Girolami, U., Smith, T., Henin, D., Hauw, J., Neuropathology of AIDS. Arch. Pathol. Lab. Med. 114 (1990), 643–655.
46. Demuis, A., Sebben, M., Haynes, L., Pin, J.-P., Bockaert, J., NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature (London) 336 (1995), 68–70.
47. Demuis, A., Pin, P.-J., Oomagari, K., Sebben, M., Bockaert, J., Arachidonic acid released from striatal neurons by joint stimulation of ionotropic and metabotropic quisqualate receptors. Nature (London) 347 (1995), 182–184.
48. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R.E., Hill, C.M., Davis, C.B., Peiper, S.C., Schall, T.J., Littman, D.R., Landau, N.R., Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 381 (1996), 661–666.
49. Denis, M., Tat protein from HIV-1 binds to Mycobacterium avium via a bacterial integrin. J. Immunol. 153 (1994), 2072–2081.
50. Dickson, D.W., Lee, S.C., Microglia in HIV-related CNS neuropathology: An update. J. Neuro-AIDS 1 (1996), 57–84.
51. Dickson, D.W., Mattiace, L.A., Kure, K., Hutchins, K., Lyman, W.D., Brosnan, C.F., Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab. Invest. 64 (1991), 135–156.
52. Dickson, D., Lee, S.C., Mattiace, L.A., Yen, S.-H.C., Brosnan, C., Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7 (1993), 75–83.
53. Dickson, D.W., Lee, S.C., Hatch, W., Mattiace, L.A., Brosnan, C.F., Lyman, W.D., Macrophages and microglia in HIV-related CNS neuropathology. Price, R.W., Perry, S.W., (eds.) “HIV, AIDS, and the Brain”, 1994, Raven Press, New York, 99–118.
54. Diop, A.G., Lesort, M., Esclaire, F., Sindou, P., Couratier, P., Hugon, J., Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci. Lett. 165 (1994), 187–190.
55. Diop, A.G., Lesort, M., Esclaire, F., Dumas, M., Hugon, J., Calbindin D28k- containing neurons, and not HSP70–expressing neurons, are more resistant to HIV-1 envelope (gp120) toxicity in cortical cell cultures. J. Neurosci. Res. 42 (1995), 252–258.
56. Di Stefano, M., Wilt, S., Gray, F., Dubois-Dalcq, M., Chiodi, F., HIV type 1 V3 sequences and the development of dementia during AIDS. AIDS Res. Hum. Retrouiruses 12 (1996), 471–476.
57. Doranz, B.J., Rucker, J., Yi, Y., Smyth, R.J., Samson, M., Peiper, S.C., Parmentier, M., Collman, R.G., Doms, R.W., A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85 (1996), 1149–1158.
58. Dragic, T., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y., Nagashima, K.A., Cayanan, C., Maddon, P.J., Koup, R.A., Moore, J.P., Paxton, W.A., HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 381 (1996), 667–673.
59. Dreyer, E.B., Kaiser, P.K., Offermann, J.T., Lipton, S.A., HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248 (1990), 364–367.
60. Endres, M.J., Clapham, P.R., Marsh, M., Ahuja, M., Turner, J.D., McKnight, A., Thomas, J.F., Stoebenau-Haggerty, B., Choe, S., Vance, P.J., Wells, T.N.C., Power, C.A., Landau, N.R., Hoxie, J.A., CD4–independent infection by HIV-2 is mediated by fusin. Cell 87 (1996), 745–756.
61. Ensoli, B., Barillari, G., Salahuddin, S.Z., Gallo, R.C., Wong-Staal, F., Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (London) 345 (1990), 84–86.
62. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R.A., Wingfield, P., Gallo, R.C., Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67 (1993), 277–287.
63. Epstein, L.G., Kuiken, C., Blumberg, B.M., Hartman, S., Sharer, L.R., Clement, M., Goudsmit, J., HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies. Virology 180 (1991), 583–590.
64. Esiri, M.M., Morris, C.S., Cellular basis of HIV infection of the CNS and the AIDS dementia complex: Oligodendrocyte. J. Neuro-AIDS 1 (1996), 133–160.
65. Esiri, M.M., Morris, C.S., Millard, P.R., Fate of oligodendrocytes in HIV-1 infection. AIDS 5 (1991), 1081–1088.
66. Evans, T.G., Rasmussen, K., Wiebke, G., Hibbs, J.B., Nitric oxide synthesis in patients with advanced HIV infection. Clin. Exp. Immunol. 97 (1994), 83–86.
67. Everall, I., Luthert, P., Lantos, P., A review of neuronal damage in human immunodeficiency virus infection: Its assessment, possible mechanism and relationship to dementia. J. Neuropathol. Exp. Neurol. 52 (1993), 561–566.
68. Everall, I.P., Glass, J.D., McArthur, J., Spargo, E., Lantos, P., Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol. 88 (1994), 538–544.
69. Falangola, M.F., Hanly, A., Galvao-Castro, B., Petito, C.K., HIV infection of human choroid plexus: A possible mechanism of viral entry into the CNS. J. Neuropathol. Exp. Neurol. 54 (1995), 497–503.
70. Falangola, M.F., Hanly, A., Galvao-Castro, B., Petito, C.K., HIV infection of human choroid plexus: A possible mechanism of viral entry into the CNS. J. Neuropathol. Exp. Neurol. 54 (1995), 497–503.
71. Feng, Y., Broder, C.C., Kennedy, P.E., Berger, E.A., HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996), 872–877.
72. Flott, B., Seifert, W., Characterization of glutamate uptake systems in astrocyte primary cultures from rat brain. Glia 4 (1991), 293–304.
73. Foster, A.C., Collins, J.F., Schwarcz, R., On the excitotoxic properties of quinolinic acid, 2,3–piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology 22 (1983), 1331–1342.
74. Frankel, A.D., Pabo, C.O., Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55 (1988), 1189–1193.
75. Gallo, P., Frei, K., Rordorf, C., Lazdins, J., Tavolato, B., Fontana, A., Human immunodeficiency virus type 1 (HIV) infection of the central nervous system: An evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23 (1989), 109–116.
76. Gallo, P., Piccinno, M.G., Krzalic, L., Tavolato, B., Tumor necrosis factor alpha (TNFα) and neurological diseases: Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumors. J. Immunol. 23 (1989), 41–44.
77. Garry, R.F., Koch, G., Tat contains a sequence related to snake neurotoxins. AIDS 6 (1992), 1541–1560.
78. Gelbard, H.A., Dzenko, K.A., DiLoreto, D., Del Cerro, C., Del Cerro, M., Epstein, L.G., Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: Implications for AIDS neuropathogenesis. Dev. Neurosci. 15 (1993), 417–422.
79. Gelbard, H.A., Nottet, H.S., Swindells, L.M.S., Jett, M., Dzenko, K.A., Genis, P., White, R., Wang, L., Choi, Y.-B., Zhang, D., Lipton, S.A., Tourtellotte, W.W., Epstein, L.G., Gendelman, H.E., Platelet-activating factor: A candidate human immunodeficiency virus type 1–induced neurotoxin. J. Virol. 68 (1994), 4628–4635.
80. Gelbard, H.A., James, H.J., Sharer, L.R., Perry, S.W., Saito, Y., Kazee, A.M., Blumberg, B.M., Epstein, L.G., Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol. 21 (1995), 208–217.
81. Genis, P., Jett, M., Bernton, E.W., Boyle, T., Gelbard, H.A., Dzenko, K., Keane, R.W., Resnick, L., Mizrachi, Y., Volsky, D.J., Epstein, L.G., Gendelman, H.E., Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176 (1992), 1703–1718.
82. Giulian, D., Wendt, E., Vaca, K., Noonan, C.A., The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 2769–2773.
83. Glass, J.D., Fedor, H., Wesselingh, S.L., McArthur, J.C., Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia. Ann. Neurol. 38 (1995), 755–762.
84. González-Scarano, F., Nathanson, N., Wong, P.K.Y., Retroviruses and the nervous system. Levy, J.A., (eds.) “The Retroviridae”, 4, 1995, Plenum Press, New York, 409–490.
85. Grant, I., Atkinson, H., Hellelink, J.R., Kennedy, C.J., Richman, D.D., Spector, S.A., McCutchan, J.A., Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann. Intern. Med. 107 (1987), 828–836.
86. Gray, F., Gherardi, R., Keohane, C., Favolini, M., Sobel, A., Poirer, J., Pathology of the central nervous system in 40 cases of acquired immune deficiency syndrome (AIDS). Neuropathol. Appl. Neurobiol. 14 (1988), 365–380.
87. Griffin, D.E., Wesselingh, S.L., McCarthur, J.C., Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann. Neurol. 35 (1994), 592–597.
88. Grimaldi, L.M.E., Martino, G.V., Franciotta, D.M., Brustia, R., Castagna, A., Pristera, R., Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1–infected patients with central nervous system involvement. Ann. Neurol. 29 (1991), 21–25.
89. Gyorkey, F., Melnick, J.L., Gyorkey, P., Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. Journal of Inf. Dis. 155 (1987), 870–876.
90. Harouse, J.M., Wroblewska, Z., Laughlin, M.A., Hickey, W.F., Schonwetter, B.S., González-Scarano, F., Human choroid plexus cells can be latently infected with human immunodeficiency virus. Ann. Neurol. 25 (1989), 406–411.
91. Harouse, J.M., Bhat, S., Spitalnik, S.L., Laughlin, M., Stefano, K., Silberberg, D.H., González-Scarano, F., Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253 (1991), 320–323.
92. Harouse, J.M., Collman, R.G., González-Scarano, F., Human immunodeficiency virus type 1 infection of SK-N-MC cells: Domains of gp120 involved in entry into a CD4–negative, galactosyl ceramide/3 sulfo-galactosyl ceramide-positive cell line. J. Virol. 69 (1995), 7383–7390.
93. Hatch, W.C., Pousada, E., Losev, L., Rashbaum, W.K., Lyman, W.D., Neural cell targets of human immunodeficiency virus type 1 in human fetal organotypic cultures. AIDS Res. Hum. Retroviruses 10 (1994), 1597–1607.
94. Hayman, M., Arbuthnott, G., Harkiss, G., Brace, H., Filippi, P., Philippon, V., Thomson, D., Vigne, R., Wright, A., Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience 53 (1993), 1–6.
95. He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W., Newman, W., Mackay, C.R., Sodroski, J., Gabuzda, D., CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (London) 385 (1997), 645–649.
96. Hesselgesser, J., Halks-Miller, M., DelVecchio, V., Peiper, S.C., Hoxie, J., Kolsoin, D.L., Taub, D., Horuk, R., Chemokine receptors in human neurons. Curr. Biol. 7 (1997), 112–121.
97. Heyes, M.P., Lackner, A., Increased cerebrospinal fluid quinolinic acid, kynurenic acid, and l-kynurenine in acute septicemia. J. Neurochem. 55 (1990), 338–341.
98. Heyes, M.P., Gravell, M., London, W.T., Eckhaus, M., Vickers, J.H., Yergey, J.A., April, M., Blackmore, D., Markey, S.P., Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macques (Macaca mulatta) naturally infected with simian retrovirus type-D. Brain Res. 531 (1990), 148–158.
99. Heyes, M.P., Brew, B.J., Martin, A., Price, R.W., Salazar, A.M., Sidtis, J.J., Yergey, J.A., Mouradian, M., Sadler, A.E., Keilp, J., Rubinow, D., Markey, S.P., Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurological status. Ann. Neurol. 29 (1991), 202–209.
100. Heyes, M.P., Saito, K., Crowley, J.S., Davis, L.E., Demitrack, M.A., Der, M., Dilling, L.A., Elia, J., Kruesi, M.J.P., Lackner, A., Larsen, S.A., Lee, K., Leonard, H.L., Markey, S.P., Martin, A., Milstein, S., Mouradian, M.M., Pranzatelli, M.R., Quearry, B.J., Salazar, A., Smith, M., Strauss, S.E., Sunderland, T., Swedo, S.W., Tourtellotte, W.W., Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115 (1992), 1249–1273.
101. Heyes, M.P., Saito, K., Markey, S.P., Human macrophages convert l-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 283 (1992), 633–635.
102. Hughes, E.S., Bell, J.E., Simmonds, P., Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. J. Virol. 71 (1997), 1272–1280.
103. Janssen, R.S., Cornblath, D.R., Epstein, L.G., Foa, R.P., McArthur, J.C., Price, R.W., Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41 (1991), 778–785.
104. Janssen, R.S., Nwanyanwu, O.C., Selik, R.M., Stehr-Green, J.K., Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42 (1992), 1472–1476.
105. Jessen, K.R., Morgan, L., Brammer, M., Mirsky, R., Galactocerebroside is expressed by non-myelin-forming Schwann cells in situ. J. Cell Biol. 101 (1985), 1135–1143.
106. Johnson, R.T., Glass, J.D., McArthur, J.C., Chesebro, B.W., Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome. Ann. Neurol. 39 (1996), 392–395.
107. Jordan, C.A., Watkins, B.A., Kufta, C., Dubois-Dalcq, M., Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent. J. Virol. 65 (1991), 736–742.
108. Jordan, E.K., Heyes, M.P., Virus isolation and quinolinic acid in primary and chronic simian immunodeficiency virus infection. AIDS 7 (1993), 1173–1179.
109. Kaiser, P.K., Offermann, J.T., Lipton, S.A., Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Neurology 40 (1990), 1757–1761.
110. Kanai, Y., Hediger, M.A., Primary structure and functional characterization of a high-affinity glutamate transporter. Nature (London) 360 (1992), 467–471.
111. Kanai, Y., Smith, C.P., Hediger, M.A., A new family of neurotransmitter transporters: The high-affinity glutamate transporters. FASEB J. 8 (1994), 1450–1459.
112. Kanai, Y., Stelzner, M., Nubberger, S., Khawaja, S., Hevert, S.C., Smith, C.P., Hediger, M.A., The neuronal and epithelial human high affinity glutamate transporter. J. Biol. Chem. 269 (1994), 20599–20606.
113. Kato, T., Hirano, A., Llena, J.F., Dembitzer, H.M., Neuropathology of acquired immune deficiency syndrome (AIDS) in 53 autopsy cases with particular emphasis on microglial nodules and multinucleated giant cells. Acta Neuropathol. 73 (1987), 287–294.
114. Kerr, S.J., Armati, P.J., Brew, B.J., Neurocytoxicity of quinolinic acid in human brain cultures. J. Neurovirol. 1 (1995), 375–380.
115. Ketzler, S., Weis, S., Haug, H., Budka, H., Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol. (Berlin) 80 (1990), 92–94.
116. Kim, S.U., Moretto, G., Lee, V., Yu, R.K., Neuroimmunology of gangliosides in human neurons and glial cells in culture. J. Neurosci. Res. 15 (1986), 303–321.
117. Kimura-Kuroda, J., Nagashima, K., Yasui, K., Inhibition of myelin formation by HIV-1 gp120 in rat cerebral cortex culture. Arch. Virol. 137 (1994), 81–99.
118. Koenig, S., Gendelman, H.E., Orenstein, J.M., Dal Canto, M.C., Pezeshkpour, G.H., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M.A., Fauci, A.S., Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233 (1986), 1089–1093.
119. Kohleisen, B., Neumann, M., Herrmann, R., Brack-Werner, R., Krohn, K.J.E., Ovod, V., Ranki, A., Erfle, V., Cellular localization of Nef expressed in persistently HIV-1–infected low-producer astrocytes. AIDS 6 (1993), 1427–1436.
120. Kolson, D.L., Pomerantz, R.J., AIDS dementia and HIV-1–induced neurotoxicity: Possible pathogenic associations and mechanisms. J. Biomed. Sci. 3 (1996), 389–414.
121. Kolson, D.L., Buchhalter, J., Collman, R., Hellmig, B., Farrell, C.F., Debouck, C., Alez-Scarano, F., HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res. Hum. Retroviruses 9 (1993), 677–685.
122. Kolson, D.L., Collman, R., Hrin, R., Balliet, J.W., Laughlin, M., McGann, K.A., Debouck, C., González-Scarano, F., Human immunodeficiency virus type 1 Tat activity in human neuronal cells: Uptake and transactivation. J. Gen. Virol. 75 (1994), 1927–1934.
123. Kondo, K., Hashimoto, H., Kitanaka, J., Sawada, M., Suzumura, A., Marunouchi, T., Baba, A., Expression of glutamate transporters in cultured glial cells. Neurosci. Lett. 188 (1995), 140–142.
124. Korber, B.T., Kunstman, K.J., Patterson, B.K., Furtado, M., McEvilly, M.M., Levy, R., Wolinsky, S.M., Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1–infected patients: Evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68 (1994), 7467–7481.
125. Kovalchuk, Y., Miller, B., Sarantis, M., Attwell, D., Arachidonic acid depresses non-NMDA receptor currents. Brain Res. 643 (1994), 287–295.
126. Kuiken, C.L., Goudsmit, J., Weiller, G.F., Armstrong, J.S., Hartman, S., Porteigies, P., Dekker, J., Cornelissen, M., Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. J. Gen. Virol. 76 (1995), 175–180.
127. Kure, K., Weidenheim, K.M., Lyman, W.D., Dickson, D.W., Morphology and distribution of HIV-1 gp41–positive microglia in subacute AIDS encephalitis. Acta Neuropathol. 80 (1990), 393–400.
128. Lane, J.H., Sasseville, V.G., Smith, M.O., Vogel, P., Pauley, D.R., Heyes, M.P., Lackner, A.A., Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/microglia and intrathecal immune activation. J. Neurovirol. 2 (1996), 423–432.
129. Lassmann, H., Schmied, M., Vass, K., Hickey, W.F., Bone marrow derived elements and resident microglia in brain inflammation. Glia 7 (1993), 19–24.
130. Laurenzi, M.A., Siden, A., Persson, M.A.A., Norkrans, G., Hagberg, L., Chiodi, F., Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. Clin. Immunol. Immunopathol. 57 (1990), 233–241.
131. Lavi, E., Strizki, J.M., Ulrich, A.M., Zhang, W., Fu, L., Wang, Q., O'Connor, M., Hoxie, J.A., González-Scarano, F., CXCR-4 (fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types including microglia and neurons. Am. J. Pathol. 151 (1997), 1035–1042.
132. Li, C.J., Friedman, D.J., Wang, C., Metelev, V., Pardee, A.B., Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268 (1995), 429–431.
133. Lipton, S.A., Memantine prevents HIV coat protein-induced neuronal injury in vivo. Neurology 42 (1992), 1403–1405.
134. Lipton, S.A., Sucher, N.J., Kaiser, P.K., Dreyer, E.B., Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7 (1991), 111–118.
135. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., MacDonald, M.E., Stuhlmann, H., Koup, R.A., Landau, N.R., Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 (1996), 367–377.
136. Magnuson, D.S., Knudsen, B.E., Geiger, J.D., Brownstone, R.M., Nath, A., Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37 (1995), 373–380.
137. Mankowski, J.L., Spelman, J.P., Ressetar, H.G., Strandberg, J.D., Laterra, J., Carter, D.L., Clements, J.E., Zink, M.C., Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J. Virol. 68 (1994), 8202–8208.
138. Mann, D.A., Frankel, A.D., Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10 (1991), 1733–1739.
139. Marshall, D.W., Brey, R.L., Cahill, W.T., Houk, R.W., Zajac, R.A., Boswell, R.N., Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch. Neurol. 45 (1988), 954–958.
140. Marshall, D.W., Brey, R.L., Butzin, C.A., Lucey, D.R., Abbadessa, S.M., Boswell, R.N., CSF changes in a longitudinal study of 124 neurologically normal HIV-1 infected U.S. Air Force personnel. J. Acquir. Immune Defic. Syndr. 4 (1991), 777–781.
141. Martin, A., Heyes, M.P., Salazar, A.M., Kampen, D.L., Williams, J., Law, W.A., Coats, M.E., Markey, S.P., Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J. Neuropsychiatry and Clinical Neurosciences 4 (1992), 270–279.
142. Masliah, E., Ge, N., Achim, C.L., Hansen, L.A., Wiley, C.A., Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51 (1992), 585–593.
143. Masliah, E., Ge, N., Morey, M., DeTeresa, R., Terry, R.D., Wiley, C.A., Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest. 66 (1992), 285–291.
144. Masliah, E., Achim, C.L., Ge, N., DeTeresa, R., Wiley, C.A., Price, R.W., Perry, S.W., (eds.) “HIV, AIDS, and the Brain”, 1994, Raven Press, New York, 119–131.
145. Masliah, E., Ge, N., Achim, C.L., DeTeresa, R., Wiley, C.A., Patterns of neurodegeneration in HIV encephalitis. J. Neuro-AIDS 1 (1996), 161–173.
146. McArthur, J.C., Neurologic manifestations of AIDS. Medicine 66 (1987), 407–437.
147. McArthur, J.C., Hoover, D.R., Bacellar, H., Miller, E.N., Cohen, B.A., Becker, J.T., Graham, N.M.H., McArthur, J.H., Selnes, O.A., Jacobson, L.P., Visscher, B.R., Concha, M., Saah, A., Dementia in AIDS patients: Incidence and risk factors. Neurology 43 (1993), 2245–2251.
148. McArthur, J.C., Selnes, O.A., Glass, J.D., Hoover, D.R., Bacellar, H., HIV dementia: incidence and risk factors. Price, R.W., Perry, S.W., (eds.) “HIV, AIDS and the Brain”, 1994, Raven Press, New York, 251–272.
149. McArthur, J.C., Seines, O.A., Human immunodeficiency virus dementia. Berger, J.R., Levy, R.M., (eds.) “AIDS and the Nervous System.”, 1997, Lippincott-Raven Publishers, Philadelphia, 527–567.
150. McCarthy, M., Wood, C., Fedoseyeva, L., Whittemore, S.R., Media components influence viral gene expression assays in human fetal astrocytes. J. Neurovirol. 1 (1995), 275–285.
151. Merrill, J.E., Chen, I.S.Y., HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5 (1991), 2391–2397.
152. Meucci, O., Miller, R.J., Gp120–induced neurotoxicity in hippocampal pyramidal neuron cultures: Protective action of TGF-β1. J. Neurosci. 16 (1996), 4080–4088.
153. Miller, B., Sarantis, M., Traynelis, S.F., Attwell, D., Potentiation of NMDA receptor currents by arachidonic acid. Nature (London) 355 (1992), 722–725.
154. Mollace, V., Colasanti, M., Persichini, T., Bagetta, G., Lauro, G.M., Nistico, G., HIV gp120 glycoprotein stimulates the inducible isoform of NO synthase in human cultured astrocytoma cells. Biochem. Biophys. Res. Commun. 194 (1993), 439–445.
155. Mollace, V., Colasanti, M., Rodino, P., Lauro, G.M., Nistico, G., HIV coating gp120 glycoprotein-dependent prostaglandin E2 release by human cultured astrocytoma cells is regulated by nitric oxide formation. Biochem. Biophys. Res. Commun. 203 (1994), 87–92.
156. Moses, A.V., Boom, F.E., Pauza, C.D., Nelson, J.A., Human immunodeficiency virus infection of human brain capillary cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 10474–10478.
157. Moses, A.V., Stenglein, S.G., Nelson, J.A., HIV infection of the brain microvasculature and its contribution to the AIDS dementia complex. J. Neuro-AIDS 1 (1996), 85–100.
158. Moses, A.V., Stenglein, S.G., Strussenberg, J.G., Wehrly, K., Chesebro, B., Nelson, J.A., Sequences regulating tropism of human immunodeficiency virus type 1 for brain capillary endothelial cells map to a unique region on the viral genome. J. Virol. 70 (1996), 3401–3406.
159. Murphy, T., Parikh, A., Schnaar, R., Coyle, J., Arachidonic acid metabolism in glutamate neurotoxicity. Ann. N.Y. Acad. Sci. 559 (1989), 474–475.
160. Narayan, O., Stephens, E.B., Joag, S.V., Chebloune, Y., Animal models of human immunodeficiency virus neurological disease. Berger, J.R., Levy, R.M., (eds.) “AIDS and the Nervous System,”, 2nd Ed, 1997, Lippincott-Raven, Philadelphia.
161. Nath, A., Psooy, K., Martin, C., Knudsen, B., Magnuson, D.S.K., Haughey, N., Geiger, J.D., Identification of a human immunodeficiency virus type 1 tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70 (1996), 1475–1480.
162. Navia, B., Cho, E.-S., Petito, C., Price, R.W., The AIDS dementia complex. II. Neuropathology. Ann. Neurol. 19 (1986), 525–535.
163. Neumann, M., Felber, B.K., Kleinschmidt, A., Froese, B., Erfle, V., Pavlakis, G.N., Brack-Werner, R., Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J. Virol. 69 (1995), 2159–2167.
164. Niikura, M., Dornadula, G., Zhang, H., Mukhtar, M., Lingxun, D., Khalili, K., Bagasra, O., Pomerantz, R.J., Mechanisms of transcriptional activation and restriction of human immunodeficiency virus type 1 replication in an astrocytic glial cell. Oncogene 13 (1996), 313–322.
165. Nokta, M.A., Hassan, M.I., Loesch, K.A., Pollard, R.B., HIV-induced TNF-α regulates arachidonic acid and PGE2 release from HIV-infected mononuclear phagocytes. Virology 208 (1995), 590–600.
166. Nottet, H.S., Jett, L.M.M., Flanagan, C.R., Zhai, Q.-H., Persidsky, Y., Rizzino, A., Bernton, E.W., Genis, P., Baldwin, T., Schwartz, J., LaBenz, C.J., Gendelman, H.E., A regulatory role for astrocytes in HIV-1 encephalitis. J. Immunol. 154 (1995), 3567–3581.
167. Nuovo, G.J., Gallery, F., MacConnell, P., Braun, A., In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Pathol. 144 (1994), 659–666.
168. Orsini, M.J., Debouck, C.M., Webb, C.L., Lysko, P.G., Extracellular human immunodeficiency virus type 1 Tat protein promotes aggregation and adhesion of cerebellar neurons. J. Neurosci. 16 (1996), 2546–2552.
169. Peluso, R., Haase, A., Stowring, L., Edwards, M., Ventura, P., A Trojan horse mechanism for the spread of visna virus in monocytes. Virology 147 (1985), 231–236.
170. Perrella, O., Carrieri, P.B., Guarnaccia, D., Soscia, M., Cerebrospinal fluid cytokines and AIDS dementia complex. J. Neurol. 239 (1992), 387–388.
171. Petito, C.K., Ependyma and choroid plexus. J. Neuro-AIDS 1 (1996), 101–110.
172. Pietraforte, D., Tritarelli, E., Testa, U., Minetti, M., Gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leuk. Biol. 55 (1994), 175–182.
173. Poland, S.D., Rice, G.P.A., Dekaban, G.A., HIV-1 infection of human brain-derived microvascular endothelial cells in vitro. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8 (1996), 437–445.
174. Power, C., McArthur, J.C., Johnson, R.T., Griffin, D.E., Glass, J.D., Perryman, S., Chesebro, B., Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J. Virol. 68 (1994), 4643–4649.
175. Power, C., McArthur, J.C., Johnson, R.T., Griffin, D.E., Glass, J.D., Dewey, R., Chesebro, B., Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr. Top. Microbiol. Immunol. 202 (1995), 89–104.
176. Price, R.W., The cellular basis of central nervous system HIV-1 infection and the AIDS dementia complex. J. Neuro-AIDS 1 (1996), 1–20.
177. Price, R.W., Brew, B., Sidtis, J., Rosenblum, J., Scheck, A.C., Cleary, P., The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex. Science 239 (1988), 586–591.
178. Price, R.W., Brew, B., Sidtis, J., Rosenblum, J., Scheck, A.C., Cleary, P., The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex. Science 239 (1988), 586–591.
179. Pulliam, L., West, D., Haigwood, N., Swanson, R.A., HIV-1 envelope gp120 alters astrocytes in human brain cultures. AIDS Res. Hum. Retroviruses 9 (1993), 439–444.
180. Pumarola-Sune, T., Navia, B.A., Cordon-Cardo, C., Cho, E.-S., Price, R.W., HIV antigen in the brains of patients with the AIDS dementia complex. Ann. Neurol. 21 (1987), 490–496.
181. Puri, R.K., Aggarwal, B.B., Human immunodeficiency virus type 1 tat gene up-regulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Res. 52 (1992), 3787–3790.
182. Raff, M.C., Lisak, R.P., Gregson, N.A., Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature (London) 274 (1978), 813–816.
183. Ranki, A., Nyberg, M., Ovod, V., Haltia, M., Elovaara, I., Raininko, R., Haapasalo, H., Krohn, K., Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9 (1995), 1001–1008.
184. Reddy, R.T., Achim, C.L., Sirko, D.A., Tehranchi, S., Kraus, F.G., Wong-Staal, F., Wiley, C.A., Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. AIDS Res. Hum. Retroviruses 12 (1996), 477–482 and the HIV Neurobehavioral Research Group.
185. Resnick, L., di Marzo-Veronese, F., Schupbach, J., Intra blood-brain-barrier synthesis of HTLV III specific IgG in patients with neurologic symptoms associated with AIDS or AIDS related complex. New Engl. J. Med. 313 (1985), 1498–1504.
186. Resnick, L., Shapshak, P., Toutellote, W.W., Early penetration of the blood-brain-barrier by HIV. Neurology 38 (1988), 9–14.
187. Robinson, M.B., Kjali, S., Buchhalter, J.R., Inhibition of glutamate uptake with l-trans-pyrrolidine-2,4–dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures. J. Neurochem. 61 (1993), 2099–2103.
188. Rothenberg, R., Woelfel, M., Stoneburner, R., Milberg, J., Parker, R., Truman, B., Survival with the acquired immunodeficiency syndrome: Experience with 5833 cases in New York City. N. Engl. J. Med. 317 (1987), 1297–1302.
189. Rothstein, J.D., Jin, L., Dykes-Hoberg, M., Kuncl, R.W., Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 6591–6595.
190. Rothstein, J.D., Martin, L., Levey, A.I., Dykes-Hoberg, M., Jin, L., Wu, D., Nash, N., Kuncl, R.W., Localization of neuronal and glial glutamate transporters. Neuron 13 (1994), 713–725.
191. Rothstein, J.C., Dykes-Hoberg, M., Pardo, C.A., Bristol, L.A., Jin, L., Kuncl, R.W., Kanai, Y., Hediger, M.A., Wang, Y., Schielke, J.P., Welty, D.F., Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16 (1996), 675–686.
192. Rucker, J., Samson, M., Doranz, B.J., Libert, F., Berson, J.J., Yi, Y., Collman, R.G., Broder, C.C., Vassart, G., Doms, R.W., Parmentier, M., Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87 (1996), 1–20.
193. Sabatier, J.M., Vives, E., Mabrouk, K., Benjouad, A., Rochat, H., Duval, A., Hue, B., Bahraoui, E., Evidence for neurotoxic activity of tat from HIV-1. J. Virol. 65 (1991), 961–967.
194. Saito, Y., Sharer, L.R., Epstien, L.G., Michaels, J., Mintz, M., Louder, M., Golding, K., Cvetkovich, T.A., Blumberg, B.M., Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44 (1994), 474–481.
195. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R.J., Collman, R.G., Doms, R.W., Vassart, G., Parmentier, M., Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (London) 382 (1996), 722–725.
196. Sasseville, V.G., Newman, W.A., Lackner, A.A., Smith, M.O., Lausen, N.C.G., Beall, D., Ringler, D.J., Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am. J. Pathol. 141 (1992), 1021–1030.
197. Sasseville, V.G., Newman, W., Brodie, S.J., Hesterberg, P., Pauley, D., Ringler, D.J., Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-/α4β1 integrin interactions. Am. J. Pathol. 144 (1994), 27–40.
198. Sasseville, V.G., Lane, J.H., Walsh, D., Ringler, D.J., Lackner, A.A., VCAM-1 expression and leukocyte trafficking to the CNS occur early in infection with pathogenic isolates of SIV. J. Med. Primatol. 24 (1995), 123–131.
199. Schacker, T., Collier, A.C., Hughes, J., Shea, T., Corey, L., Clinical and epidemiological features of primary HIV infection. Ann. Intern. Med. 125 (1996), 257–264.
200. Schneider-Schaulies, J., Schneider-Schaulies, S., Brinkman, R., Tas, P., Halbrugge, M., Walter, U., Holmes, H.C., Ter Meulen, V., HIV-1 gp120 receptor on CD4–negative brain cells activates a tyrosine kinase. Virology 191 (1992), 765–772.
201. Schwarcz, R., Whetsell, W.O., Mangano, R.M., Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219 (1983), 316–318.
202. Sei, S., Stewart, S.K., Farley, M., Mueller, B.U., Lane, J.R., Robb, M.L., Brouwers, P., Pizzo, P.A., Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy. J. Infect. Dis. 174 (1996), 1200–1206.
203. Seilhean, D., Duyckaerts, C., Vazeux, R., Bolgert, F., Brunet, P., Katlama, C., Gentilini, M., Hauw, J.-J., HIV-1–associated cognitive/motor complex: Absence of neuronal loss in the cerebral neocortex. Neurology 43 (1993), 1492–1499.
204. Sharer, L.R., Pathology of HIV-1 infection of the central nervous system. A review. J. Neuropath. Exp. Neurol. 51 (1992), 3–11.
205. Sharer, L.R., Neuropathology and pathogenesis of SIV infection of the central nervous system. Price, R.W., Perry, S.W., (eds.) “HIV, AIDS and the Brain”, 1994, Raven Press, New York, 133–146.
206. Sharer, L.R., Prineas, J.W., Human immunodeficiency virus in glial cells?. J. Infect. Dis., 157, 1988, 204.
207. Sharer, L.R., Epstein, L.G., Cho, E.-S., Joshi, V.-V., Meyenhofer, M.F., Rankin, L.F., Petito, C.K., Pathologic features of AIDS encephalopathy in children: Evidence for LAV/HTLV-III infection of brain. Hum. Pathol. 17 (1986), 271–284.
208. Sharpe, A.H., Hunter, J.J., Chassier, P., Jaenisch, R., Role of abortive retroviral infection of neurons in spongiform CNS degeneration. Nature (London) 346 (1990), 181–183.
209. Sidtis, J.J., Price, R.W., Perry, S.W., (eds.) “HIV, AIDS and the Brain”, 1994, Raven Press, New York, 273–287.
210. Sinclair, E., Gray, F., Ciardi, A., Scaravilli, F., Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J. Neuropath. Exp. Neurol. 53 (1994), 43–50.
211. Shrikant, P., Benos, D.J., Tang, L.-P., Benveniste, E.N., HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. J. Immunol. 156 (1996), 1307–1314.
212. Sloan, D.J., Wood, M.J., Charlton, H.M., Leucocyte recruitment and inflammation in the CNS. Trends NeuroSci. 15 (1992), 276–278.
213. Spector, S.A., Hsia, K., Pratt, D., Lathey, J., McCutchan, J.A., Alcaraz, J.E., Arkinson, J.H., Gulevich, S., Wallace, M., Grant, I., Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. J. Infect. Dis. 168 (1993), 68–74 and the HIV Neurobehavioral Research Center Group.
214. Stefano, G.B., Sawada, M., Smith, E.M., Hughes, T.K., Selective effects of human immunodeficiency virus (HIV) gp120 on invertebrate neurons. Cell. Mol. Neurobiol. 13 (1994), 569–577.
215. Strizki, J.M., Albright, A.V., Sheng, H., O'Connor, M., Perrin, L., González-Scarano, F., Infection of primary human microglia and monocyte-derived macrophages with acute HIV-1 isolates: Evidence of differential tropism. J. Virol. 70 (1996), 7564–7662.
216. Subramanyam, M., Gutheil, W.G., Bachovchin, W.W., Huber, B.T., Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol. 150 (1993), 2544–2553.
217. Tardieu, M., Janabi, N., HIV-1 and the developing human nervous system: In vivo and in vitro aspects. Dev. Neurosci. 16 (1994), 137–144.
218. Taylor, J.P., Cupp, C., Diaz, A., Chowdhury, M., Khalili, K., Jimenez, S.A., Amini, S., Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992), 9617–9621.
219. Teoh, R., Humphries, M., Tuberculous meningitis. Lambert, H.P., (eds.) “Infections of the Central Nervous System”, 1991, B. C. Decker, Philadelphia, 189–207.
220. Thomas, F.P., Chalk, C., Lalonde, R., Robitaille, Y., Jolicoeur, P., Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurologic disease. J. Virol. 68 (1994), 7099–7107.
221. Toggas, S.M., Masliah, E., Rockenstein, E.M., Rall, G.F., Abraham, C.R., Mucke, L., Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature (London) 367 (1994), 188–193.
222. Tong, G., Jahr, C.E., Block of glutamate transporters potentiates postsynaptic excitation. Neuron 13 (1994), 1195–1203.
223. Tornatore, C., Nath, A., Amemiya, K., Major, E.O., Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J. Virol. 65 (1993), 6094–6100.
224. Tornatore, C., Chandra, R., Berger, J.R., Major, E.O., HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44 (1994), 481–487.
225. Truckenmiller, M.E., Kulaga, H., Coggiano, M., Wyatt, R., Snyder, S.H., Sweetnam, P.M., Human cortical neuronal cell line: A model for HIV-1 infection in an immature neuronal system. AIDS Res. Hum. Retroviruses 9 (1993), 445–453.
226. Tyler, K.L., González-Scarano, F., Viral disease of the CNS: Acute infections. Nathanson, N., Ahmed, R., González-Scarano, F., Griffin, D.E., Holmes, K.V., Murphy, F.A., Robinson, H.L., (eds.) “Viral Pathogenesis”, 1997, Lippincott-Raven, Philadelphia, 837–853.
227. Tyor, W.R., Glass, J.D., Griffin, J.W., Becker, P.S., McArthur, J.C., Bezman, L., Griffin, D.E., Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31 (1992), 349–360.
228. Vesanen, M., Salminen, M., Wessman, M., Lankinen, H., Sistonen, P., Vaheri, A., Morphological differentiation of human SH-SY5Y neuroblastoma cells inhibits human immunodeficiency virus type 1 infection. J. Gen. Virol. 75 (1994), 201–206.
229. Vinters, H.V., The acquired immunodeficiency syndrome (AIDS) dementia complex. [D.D. Ho, moderator]. Ann. Intern. Med. 111 (1989), 400–410.
230. Vogel, B.E., Lee, S.-J., Hildebrand, A., Craig, W., Pierschbacher, M.D., Wong-Staal, F., Ruoslahti, E., A novel integrin specificity exemplified by binding of the αvβ5 integrin to the basic domain of the HIV Tat protein and vitronectin. J. Cell Biol. 121 (1993), 461–468.
231. Vornov, J.J., Tasker, R.C., Park, J., Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/kainate receptors in organotypic hippocampal cultures. Exp. Neurol. 133 (1995), 7–17.
232. Wahl, S.M., Allen, J.B., McCartney-Francis, N., Morganti-Kossmann, M.C., Kossmann, T., Ellingsworth, L., Mai, U.E.H., Mergenhagen, S.E., Orenstein, J.M., Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. Exp. Med. 173 (1991), 981–991.
233. Watry, D., Lane, T.E., Streb, M., Fox, H.S., Transfer of neuropathogenic siminan immunodeficiency virus with naturally infected microglia. Am. J. Pathol. 146 (1995), 914–923.
234. Weeks, B.S., Desai, K., Loewenstein, P.M., Klotman, M.E., Klotman, P.E., Green, M., Kleinman, H.K., Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90–kDa cell surface binding protein. J. Biol. Chem. 268 (1993), 5279–5284.
235. Weeks, B.S., Lieberman, D.M., Johnson, B., Roque, E., Green, M., Loewenstein, P., Oldfield, E.H., Kleinman, H.K., Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires the tat amino acid 49–58 basic domain. J. Neurosci. Res. 42 (1995), 34–40.
236. Weidenheim, K.M., Epshteyn, I., Lyman, W.D., Immunocytochemical identification of T-cells in HIV-1 encephalitis: Implications for pathogenesis of CNS disease. Mod. Pathol. 6 (1993), 167–174.
237. Weis, S., Haug, H., Budka, H., Astroglial changes in the cerebral cortex of AIDS brains: A morphometric and immunohistochemical investigation. Neuropathol. Appl. Neurobiol. 19 (1993), 329–335.
238. Werner, T., Ferroni, S., Saermark, T., Brack-Werner, R., Bannati, R.B., Mager, R., Steinaa, L., Kreutzberg, G.W., Erfle, V., HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. AIDS 5 (1991), 1301–1308.
239. Wesselingh, S.L., Power, C., Glass, J.D., Tyor, W.R., McArthur, J.C., Farber, J.M., Griffin, J.W., Griffin, D.E., Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33 (1993), 576–582.
240. Westerndorp, M.O., Li-Weber, M., Frank, R.W., Krammer, P.H., Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68 (1994), 4177–4185.
241. Westmoreland, S.V., Kolson, D., González-Scarano, F., Toxicity of TNFα and platelet activating factor for human NT2N neurons: A tissue culture model for human immunodeficiency virus dementia. J. Neurovirol. 2 (1996), 118–126.
242. Whetsell, W.O., Schwarcz, R., Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci. Lett. 97 (1989), 271–275.
243. Wiley, C.A., Achim, C.A., Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol. 36 (1994), 673–676.
244. Wiley, C.A., Schrier, R.D., Nelson, J.A., Lampert, P.W., Oldstone, M.B.A., Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 7089–7093.
245. Wiley, C.A., Masliah, E., Morey, M., Lemere, C., DeTeresa, R., Grafe, M., Hansen, L., Terry, R., Neocortical damage during HIV infection. Ann. Neurol. 29 (1991), 651–657.
246. Wiley, C.A., Baldwin, M., Achim, C.L., Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10 (1996), 843–847.
247. Williams, K.C., Hickey, W.F., Traffic of lymphocytes into the CNS during inflammation and HIV infection. J. Neuro-AIDS 1 (1996), 31–55.
248. Wilt, S.G., Milward, E., Zhou, J.M., Nagasato, K., Patton, H., Rusten, R., Griffin, D.E., O'Connor, M., Dubois-Dalcq, M., In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 37 (1995), 381–394.
249. Yeung, M.C., Pulliam, L., Lau, A.S., The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-α. AIDS 9 (1995), 137–143.
250. Zauli, G., Davis, B.R., Re, M.C., Visani, G., Furlini, G., La Placa, M., Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: A potential mechanism for human immunodeficiency virus-1–induced hematopoietic suppression. Blood 80 (1992), 3036–3043.